BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28665480)

  • 1. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
    Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
    Schachtner T; Zaks M; Kahl A; Reinke P
    Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients.
    Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
    Transpl Infect Dis; 2018 Apr; 20(2):e12848. PubMed ID: 29359836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
    Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
    Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infection.
    Schachtner T; Stein M; Reinke P
    Transpl Int; 2016 Dec; 29(12):1296-1306. PubMed ID: 27638250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
    Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
    Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
    Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
    Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO desensitization affects cellular immunity and infection control after renal transplantation.
    Schachtner T; Stein M; Reinke P
    Transpl Int; 2015 Oct; 28(10):1179-94. PubMed ID: 26033637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
    Schachtner T; Stein M; Reinke P
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant.
    Aziz F; Jorgenson MR; Parajuli S; Zhong W; Hidalgo LG; Djamali A; Mandelbrot D; Odorico J; Sollinger H; Astor BC; Mohamed MA
    Transpl Infect Dis; 2020 Jun; 22(3):e13272. PubMed ID: 32112710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor.
    Schachtner T; Stein M; Reinke P
    Transplantation; 2017 Oct; 101(10):e315-e325. PubMed ID: 28594749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
    Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
    Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
    Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
    BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
    Wisgerhof HC; van der Boog PJ; de Fijter JW; Wolterbeek R; Haasnoot GW; Claas FH; Willemze R; Bouwes Bavinck JN
    J Invest Dermatol; 2009 Dec; 129(12):2886-94. PubMed ID: 19571820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation.
    Kaufman DB; Leventhal JR; Gallon LG; Parker MA; Koffron AJ; Fryer JP; Abecassis MM; Stuart FP
    Transplantation; 2001 Dec; 72(12):1940-5. PubMed ID: 11773893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study.
    Schachtner T; Reinke P
    Transpl Infect Dis; 2016 Dec; 18(6):881-888. PubMed ID: 27632022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different risk factor profiles distinguish early-onset from late-onset BKV-replication.
    Schachtner T; Babel N; Reinke P
    Transpl Int; 2015 Sep; 28(9):1081-91. PubMed ID: 25959355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
    Shah AP; Chen JM; Fridell JA
    Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
    Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
    Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.